- Federal agenciesProvides predictable federal funding for mosquito and vector surveillance and control programs.
- Potential benefitSupports workforce development through technical assistance and up to 5% funding for continuing education.
- Potential benefitEncourages adoption and piloting of innovative mosquito control technologies through grant considerations.
SMASH 2.0 Act
Referred to the House Committee on Energy and Commerce.
This bill (SMASH 2.0) reauthorizes and updates section 317S of the Public Health Service Act to support mosquito- and vector-borne disease surveillance and control. It provides $100 million per year for fiscal years 2026–2030, allows the CDC to fund technical assistance and training, permits recipients to use up to 5% of awards for continuing education, explicitly allows consideration of innovative vector-control technologies in grants, and directs CDC and ASPR to plan for emergency stockpiling of nonperishable vector-control products within the Strategic National Stockpile.
Support for federal funding versus concern about ongoing federal spending
Relative to its intended legislative type, this bill clearly functions as a substantive reauthorization and modest expansion of an existing vector-control grant program: it provides multiyear funding authorization, names implementing officials, authorizes technical assistance and education, allows consideration of new technologies, and adds coordination for a Strategic National Stockpile of vector-control products.
This bill (SMASH 2.0) reauthorizes and updates section 317S of the Public Health Service Act to support mosquito- and vector-borne disease surveillance and control.
It provides $100 million per year for fiscal years 2026–2030, allows the CDC to fund technical assistance and training, permits recipients to use up to 5% of awards for continuing education, explicitly allows consideration of innovative vector-control technologies in grants, and directs CDC and ASPR to plan for emergency stockpiling of nonperishable vector-control products within the Strategic National Stockpile.
Technocratic reauthorization with modest fiscal impact and few ideological flashpoints, historically the type of bill that can clear both chambers.
Relative to its intended legislative type, this bill clearly functions as a substantive reauthorization and modest expansion of an existing vector-control grant program: it provides multiyear funding authorization, names implementing officials, authorizes technical assistance and education, allows consideration of new technologies, and adds coordination for a Strategic National Stockpile of vector-control products. However, it leaves many operational specifics, definitional boundaries, oversight requirements, and safety or procurement safeguards to agency implementation.
Support for federal funding versus concern about ongoing federal spending
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Federal agenciesAuthorizes $100 million annually, creating a federal cost of roughly $500 million over five years if appropriated.
- ManufacturersExpanded stockpiling and procurement could favor specific manufacturers, raising concerns about market effects.
- Potential burdenEncouraging novel technologies could introduce unproven methods with uncertain safety or environmental effects.
Why the argument around this bill splits.
Support for federal funding versus concern about ongoing federal spending
Generally supportive: the bill restores stable federal funding, invests in workforce training, and enables new technologies to address growing vector threats.
They will want stronger environmental and civil-society safeguards, equity in funding, and transparency about novel technologies and procurement.
Cautiously favorable: the bill is a pragmatic reauthorization that strengthens preparedness and workforce capacity.
They will seek measurable outcomes, fiscal accountability, and clear limits on federal roles versus state/local implementation.
Mixed to somewhat skeptical: supports protecting public health but worries about federal overreach, recurring spending, and open-ended language about novel technologies.
Prefers state control, tighter spending oversight, and limits on federal stockpiling authority.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Technocratic reauthorization with modest fiscal impact and few ideological flashpoints, historically the type of bill that can clear both chambers.
- Whether appropriators will fund full authorized amounts
- Potential pushback over use of novel genetic or chemical control methods
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Support for federal funding versus concern about ongoing federal spending
Technocratic reauthorization with modest fiscal impact and few ideological flashpoints, historically the type of bill that can clear both c…
Relative to its intended legislative type, this bill clearly functions as a substantive reauthorization and modest expansion of an existing vector-control grant program: it provides multiyear funding authorization, name…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.